pharmaphorum April 11, 2024
Jonah Comstock

It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another. How did we get here? And how do we get past it?

On today’s pharmaphorum podcast, host Jonah Comstock speaks with Iddo Peleg, CEO of Yonalink, about these very questions.

They discuss the difficulty of innovating in an extremely risk-averse industry like pharma, the downsides of manual data capture, and some of the difficulties involved in automating...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Conferences / Podcast, EMR / EHR, Health IT, Technology, Trends
When Medical A.I. is Lifesaving
STAT+: Doctors Without Borders challenges pharma by releasing costs for a key clinical trial
Systems thinking: A new paradigm for clinical trial design and operations
Duchenne Muscular Dystrophy: the global clinical trials landscape 2024
STAT+: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition

Share This Article